Those who suffer from rosacea know that the current treatments don’t work very well. There may be a new intriguing rosacea treatment and it involves treating intestinal bacteria. Small intestinal bacterial overgrowth was more common in rosacea patients; and those who were treated with rifaximin (an antibiotic) for bacterial overgrowth had improvement in rosacea, according to a new study presented at the annual meeting of the American College of Gastroenterology.
A relationship between skin and gut problems has been shown before and now this small series showed that rosacea improved when patients with small intestinal bacterial overgrowth (SIBO) were treated with rifaximin. Patients with both small intestinal bacterial overgrowth and rosacea were treated with rifaximin; 46% showed clearance of, or marked improvement in, rosacea symptoms while another 25% showed moderate improvement.
Stay tuned as a large trial is underway to further explore the possible benefits of rifaximin in patients with rosacea and small intestinal bacterial overgrowth.
- Dr O.